If AGT103-T can inhibit replication in latently infected cells, are you hoping for a functional cure but not expecting a sterilizing cure that eliminates all infected cells?

American Gene Technologies® scientists believe the best way to fight a virus is nature’s way: have a strong immune response. Unfortunately, HIV evolved to defeat immunity by destroying CD4 cells, which are the driving force for all immune reactions capable of eradicating viruses. We developed the AGT103-T product to come as close as we can to repairing the damage done by HIV. If it is successful, the treatment should restart a normal immune response against HIV and, we hope, lead to controlling virus replication and eventually removing the infected cells.